October 20, 2025

FDA Okays First Oral GLP-1 for CV Risk

Novo Nordisk’s once-daily GLP-1 tablet reduced major adverse cardiovascular events in high-risk adults, including those without prior heart attack or stroke.

Conexiant

October 15, 2025

Study Describes Patterns in Reported Drug Interactions

Researchers analyze about 177,000 drug interactions to identify key medication safety trends.

Conexiant

October 07, 2025

EASO Issues Obesity Pharmacotherapy Guidance

EASO framework guides obesity drug selection by weight loss effect and complication focus.

Conexiant

October 03, 2025

Court Upholds State's "Doctor" Title Ban

Federal judge rules nurse practitioners with doctorates cannot use “doctor/Dr.” in advertising or health care settings likely to make patients think they’re physicians. 

Conexiant

September 30, 2025

Physician Shortages Loom Amid Policy Shifts

Health care drives the year’s employment growth—yet limits on immigrant labor and looming Medicaid reductions could sap momentum and leave hospitals and home care struggling to hire.

KFF Health News

September 29, 2025

The 7-Day Risk ACIP Didn't Address

Delaying newborn hepatitis B shots may leave infants exposed to everyday transmission risks.

KFF Health News

September 29, 2025

Top 10 States to Practice Family Medicine

The following list highlights the states that offer the most favorable conditions for family physicians.

Conexiant

September 24, 2025

Surgery Versus GLP-1: Long-Term Diabetes Outcomes

Metabolic surgery associated with lower mortality and retinopathy risk versus glucagon-like peptide-1 therapy in diabetes and obesity.

Conexiant

September 23, 2025

Global Consensus Streamlines MASLD/MASH Care

"We have developed consensus recommendations for busy clinicians."

Conexiant